If I were to hazard a guess, I would guess around $2.20 to $2.50. End of February we learn who bought the $18 million in shares. We will also learn a timeline that has been withheld from shareholders. More patents by then. A lot of disclosure will force to happen. And McNally understands he will be out of a job if shareholders get crappy news. Now that NASDAQ requirements are behind us, it may open the door for possible dilution to get us past FDA. We all talk about Medtronic buying us out. I suspect it will happen. On the chance that it does not and Titan will not be bought out and decide to go it alone, a raise is needed. If this does happen, it should occur with news of a finalized timeline. Investors will buy up the raise knowing the end is in sight. McNally will keep his job because shareholders understand the finish line is upon us. Shareholders will see Titan is now showing transparency. Again, I feel we will be bought out or Medtronic may continue to fund us.
You also have to ask “Who will market ENOS and who will manufacture and distribute? We do not have a sales force either.
If we go it alone with a timeline to completion and dilution it will not be a bad thing. We will all realize that as we get to the end of FDA fully funded they will have to be bought out as it would take even more resources to sell ENOS, resources we don’t have.
I truly believe the photo CRNA posted was truth. We will get to FDA by end of 2021.
Just my two cents.
McNally is not in a position to hit us with bad news as he will be unemployed. He is also a puppet with Medtronic pulling the strings anyway.
Another thing to think about. We know we will get $41 million total from Medtronic. If there is no raise this quarter, we know we cannot afford to get through FDA. So how to we pay for it as time ticks by? A buyout would do it.
